203 related articles for article (PubMed ID: 11885959)
1. Differential binding mode of diverse cyclooxygenase inhibitors.
Llorens O; Perez JJ; Palomer A; Mauleon D
J Mol Graph Model; 2002 Mar; 20(5):359-71. PubMed ID: 11885959
[TBL] [Abstract][Full Text] [Related]
2. The structures of prostaglandin endoperoxide H synthases-1 and -2.
Garavito RM; Malkowski MG; DeWitt DL
Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():129-52. PubMed ID: 12432914
[TBL] [Abstract][Full Text] [Related]
3. Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2.
Luong C; Miller A; Barnett J; Chow J; Ramesha C; Browner MF
Nat Struct Biol; 1996 Nov; 3(11):927-33. PubMed ID: 8901870
[TBL] [Abstract][Full Text] [Related]
4. Molecular modelling of the differential interaction between several non-steroidal anti-inflammatory drugs and human prostaglandin endoperoxide H synthase-2 (h-PGHS-2).
Pouplana R; Lozano JJ; Ruiz J
J Mol Graph Model; 2002 Jan; 20(4):329-43. PubMed ID: 11858641
[TBL] [Abstract][Full Text] [Related]
5. Docking studies on NSAID/COX-2 isozyme complexes using contact statistics analysis.
Ermondi G; Caron G; Lawrence R; Longo D
J Comput Aided Mol Des; 2004 Nov; 18(11):683-96. PubMed ID: 15865061
[TBL] [Abstract][Full Text] [Related]
6. Structural approach for COX-2 inhibition.
Michaux C; Charlier C
Mini Rev Med Chem; 2004 Aug; 4(6):603-15. PubMed ID: 15279594
[TBL] [Abstract][Full Text] [Related]
7. The cyclooxygenase isoforms: structural insights into the conversion of arachidonic acid to prostaglandins.
Garavito RM; DeWitt DL
Biochim Biophys Acta; 1999 Nov; 1441(2-3):278-87. PubMed ID: 10570255
[TBL] [Abstract][Full Text] [Related]
8. COX-2 selectivity and inflammatory processes.
van Ryn J; Trummlitz G; Pairet M
Curr Med Chem; 2000 Nov; 7(11):1145-61. PubMed ID: 11032964
[TBL] [Abstract][Full Text] [Related]
9. Structural basis for selective inhibition of COX-2 by nimesulide.
Fabiola GF; Pattabhi V; Nagarajan K
Bioorg Med Chem; 1998 Dec; 6(12):2337-44. PubMed ID: 9925294
[TBL] [Abstract][Full Text] [Related]
10. The cyclooxygenase-2 structure: new drugs for an old target?
Garavito RM
Nat Struct Biol; 1996 Nov; 3(11):897-901. PubMed ID: 8901861
[No Abstract] [Full Text] [Related]
11. Structural basis of the dynamic mechanism of ligand binding to cyclooxygenase.
Llorens O; Perez JJ; Palomer A; Mauleon D
Bioorg Med Chem Lett; 1999 Oct; 9(19):2779-84. PubMed ID: 10522690
[TBL] [Abstract][Full Text] [Related]
12. The structure of mammalian cyclooxygenases.
Garavito RM; Mulichak AM
Annu Rev Biophys Biomol Struct; 2003; 32():183-206. PubMed ID: 12574066
[TBL] [Abstract][Full Text] [Related]
13. Design of selective inhibitors of cyclooxygenase-2 as nonulcerogenic anti-inflammatory agents.
Marnett LJ; Kalgutkar AS
Curr Opin Chem Biol; 1998 Aug; 2(4):482-90. PubMed ID: 9736921
[TBL] [Abstract][Full Text] [Related]
14. Chemometric rationalization of the structural and physicochemical basis for selective cyclooxygenase-2 inhibition: toward more specific ligands.
Filipponi E; Cecchetti V; Tabarrini O; Bonelli D; Fravolini A
J Comput Aided Mol Des; 2000 Mar; 14(3):277-91. PubMed ID: 10756482
[TBL] [Abstract][Full Text] [Related]
15. Rationale for the observed COX-2/COX-1 selectivity of celecoxib from Monte Carlo simulations.
Price ML; Jorgensen WL
Bioorg Med Chem Lett; 2001 Jun; 11(12):1541-4. PubMed ID: 11412976
[TBL] [Abstract][Full Text] [Related]
16. Determination of expression of cyclooxygenase-1 and -2 isozymes in canine tissues and their differential sensitivity to nonsteroidal anti-inflammatory drugs.
Wilson JE; Chandrasekharan NV; Westover KD; Eager KB; Simmons DL
Am J Vet Res; 2004 Jun; 65(6):810-8. PubMed ID: 15198222
[TBL] [Abstract][Full Text] [Related]
17. Structure-based QSAR study on differential inhibition of human prostaglandin endoperoxide H synthase-2 (COX-2) by nonsteroidal anti-inflammatory drugs.
Pouplana R; Lozano JJ; Pérez C; Ruiz J
J Comput Aided Mol Des; 2002 Oct; 16(10):683-709. PubMed ID: 12650588
[TBL] [Abstract][Full Text] [Related]
18. Cox-2-selective inhibitors: the new super aspirins.
DeWitt DL
Mol Pharmacol; 1999 Apr; 55(4):625-31. PubMed ID: 10101019
[No Abstract] [Full Text] [Related]
19. Identification of novel cyclooxygenase-2 selective inhibitors using pharmacophore models.
Palomer A; Cabré F; Pascual J; Campos J; Trujillo MA; Entrena A; Gallo MA; García L; Mauleón D; Espinosa A
J Med Chem; 2002 Mar; 45(7):1402-11. PubMed ID: 11906281
[TBL] [Abstract][Full Text] [Related]
20. Structure-based design of COX-2 selectivity into flurbiprofen.
Bayly CI; Black WC; Léger S; Ouimet N; Ouellet M; Percival MD
Bioorg Med Chem Lett; 1999 Feb; 9(3):307-12. PubMed ID: 10091674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
